How To YieldBoost Zimmer Biomet Holdings To 7.7% Using Options

Zimmer Biomet Holdings (ZBH) is highlighted for a potential covered call strategy involving selling a January 2027 $110 strike call, given its 27% trailing 12-month volatility and current price of $100.20. Concurrently, S&P 500 options trading indicates strong bullish sentiment, with a put:call ratio of 0.43, significantly below the long-term median of 0.65, reflecting a notable preference for calls among options buyers.

Analysis

Zimmer Biomet Holdings (ZBH), trading at $100.20, is presented as a candidate for a covered call strategy, specifically the sale of a January 2027 call option at a $110 strike price. The stock's trailing twelve-month volatility is calculated at 27%, a key metric for pricing this option and assessing its potential for income generation against the risk of forfeiting capital gains above the $110 strike. While the article raises the question of whether its approximate 1% annualized dividend yield is sustainable, tying it to corporate profitability, it provides no fundamental analysis to form a conclusion. Separately, the broader market exhibits strong bullish sentiment in options trading, evidenced by the S&P 500 components' put:call ratio of 0.43. This figure is significantly below the long-term median of 0.65, indicating a pronounced preference for call options among traders on the day of the report.

Key Decisions for Investors

• Investors holding Zimmer Biomet (ZBH) should evaluate the proposed January 2027 covered call at the $110 strike as a potential yield-enhancement strategy, using the stock's 27% volatility to generate premium income while accepting a cap on upside potential.
• Given the article's flagged uncertainty regarding the dividend, it is crucial to conduct further due diligence on ZBH's profitability and cash flow to assess the sustainability of its 1% yield before factoring it into total return projections.
• While the S&P 500's low put:call ratio of 0.43 signals broad market bullishness, this should be treated as a potential market tailwind and not a direct bullish signal for ZBH, whose performance will remain contingent on company-specific factors.